Denis Burger

Epitope, Inc, operates through its subsidiaries. The company provides and develops diagnostic tests and devices for the detection of Human immunodeficiency virus (HIV) through its subsidiary. The company's products include OraSure, an oral specimen collection device and EPIblot, a serum-based Western blot confirmatory test kit. The prime customers of the company includes life insurance companies, prison systems, the military, and colleges and universities. The products are marketed in United States, Canada, Europe, Asia, Latin America and other countries. It is located in Beaverton, OR.

Paulson Capital (Delaware) Corp. operates as a holding company for Paulson Investment Co., which is a full service brokerage firm engaged in the purchase and sales of securities from and to the public, as well as its own account, and investment banking activities. The company was founded by Chester L. F. Paulson in 1970 and is headquartered in Portland, OR.

AMES Technology, Inc. focuses on developing innovative medical devices in the field of neurorehabilitation. It is now poised to commercialize the first of its products - the AMES Rehabilitation Therapy Medical Device. The company is headquartered in Portland, OR.

BioCurex, Inc. engages in the business of developing, producing, marketing and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It focuses on developing and commercializing products for the early detection, diagnosis, and monitoring the recurrence of cancer. It has developed a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. RECAF is a molecule found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells and it also can be used in blood tests to determine if a patient has cancer. The company was founded by Ricardo Moro-Vidal on December 8, 1997 and is headquartered in Richmond, Canada.